1 – 15 of 17
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Development of in vitro models that test and predict immune-mediated adverse toxicities
(
- Master (Two yrs)
-
Mark
Interactome Mapping of Plasminogen-interactive Proteins from Group A Streptococcus by Integrated Mass Spectrometry-based Proteomics
(
- Master (Two yrs)
-
Mark
Development and testing of autologous in vitro models for their ability to mimic the immune system’s response toward immunotherapies
(
- Master (Two yrs)
-
Mark
Towards Development of Antibodies Targeting Myeloid and Regulatory T Cells in Bladder Tumours
(
- Master (Two yrs)
-
Mark
Mass spectrometry-based proteomic characterization of peripheral immune cells
(
- Master (Two yrs)
-
Mark
Comparative proteomic analysis of adult LMPPs and leukemic cells under stimulation of IFNa
(
- Master (Two yrs)
- 2022
-
Mark
Preparation of Cell Model Systems for Digital Spatial Profiling
(
- Master (Two yrs)
-
Mark
In vitro differentiation of human myeloid cell populations.
(
- Master (Two yrs)
- 2021
-
Mark
Optimization of protocol for in vitro generation of HPV-specific T-cell lines
(
- Master (Two yrs)
- 2020
-
Mark
Peripheral Immune Cell Signatures and Risk for Alzheimer’s Disease
(
- Master (Two yrs)
-
Mark
An analysis of the IgE-encoding transcriptome in response to Phl p 2 in individuals lacking stereotypical immune response
(
- Master (Two yrs)
- 2019
-
Mark
Mechanisms of “cocktail effects” in skin sensitization – investigation of (danger) signal integration and the role of autophagy in a dendritic cell model
(
- Master (Two yrs)
-
Mark
Design and characterization of 3D cultures in oropharyngeal squamous cell carcinoma
(
- Master (Two yrs)
- 2016
-
Mark
Developing AFFIRM assays for detection of potential biomarkers for relapsed breast cancer in plasma
(
- Master (Two yrs)
-
Mark
An AFFIRM Assay for Potential Biomarkers in Relapsed Breast Cancer
(
- Master (Two yrs)